It has been hypothesized that bacterial debris may accumulate in tissues of the reticuloendothelial system (RES) serving as an inflammatory stimulus for human disease. In support of this hypothesis, muramic acid (Mur), a component of bacterial peptidoglycan (PG), has previously been reported to be present in culturenegative human spleen. High-performance liquid chromatography (HPLC) was employed in these analyses, and a peak was detected at the retention time of Mur. However, HPLC is best used as a screening technique, and it is vital that these tentative observations be reexamined by the state-of-the-art approach (gas chromatography-tandem mass spectrometry [GC-MS 2 ]). Indeed, in the present work using GC-MS 2 , Mur was not detected in six out of seven human spleens previously examined by HPLC. However, Mur was categorically detected at minute concentrations, 50 ppb, in one spleen. In conclusion, since Mur is not generally found in culture-negative human spleen, in future studies, these tissues can serve as negative controls. The study of Mur levels in inflammation (e.g., reactive arthritis) could prove important in testing the hypothesis that bacterial debris persisting in tissues could serve as a depot inciting diseases of unknown etiology.
Reactive arthritis is defined as a nonpurulent joint inflammation developing after infection elsewhere in the body (10) . The inflammation occurs despite organisms rarely being cultured from the joint (10, 18) . Forms of reactive arthritis where bacteria have been shown to play a role include Lyme disease (37) , rheumatic fever (41) , and Reiters sydrome (1, 6, 39) .
The etiology of rheumatoid arthritis is not clearly understood. It is widely accepted that the pathogenesis of rheumatoid arthritis includes the presentation of an unknown arthritogenic antigen to helper T cells (40) . Activated CD4 ϩ T cells are thought to stimulate macrophages to produce pro-inflammatory cytokines (e.g., tumor necrosis factor alpha and interleukin-1) that play a major part in stimulating the inflammatory response (4) . Reactive arthritis and rheumatoid arthritis may share a common etiology, and it might be premature to rule out a role for bacteria in the latter.
In experimental models of arthritis, sterile bacterial cell wall fragments injected intraperitoneally into rats cause chronic inflammation in joints where small amounts of bacterial debris accumulate (8, 12, 17, 26, 33, 34, 35, 38) . The majority of this material, however, localizes in the mononuclear, phagocytic system and is only slowly eliminated over time (12, 17, 35, 36) . Mammalian enzymes, including lysozyme (16) and muramyl-L-alanine amidase, have limited activity on many gram-positive bacterial cell walls (25) . However, it has been recently demonstrated using gas chromatography-tandem mass spectrometry (GC-MS 2 ) that Mur is not present in normal rat spleen (23) . Mur (3-O-lactyl-glucosamine) is an amino sugar present in PG backbones of gram-positive and gram-negative bacteria. It is not synthesized by mammalian enzyme systems and therefore serves as a chemical marker to indicate the presence of viable bacteria as well as their nonviable cell wall remnants. These remnants have been shown to play a direct role in the disease process by activating cytokines and promoting acute inflammation (5, 19) .
It can be hypothesized that, in patients with an underlying disease process (e.g., colon cancer or Chrohn's disease), inflammation or trauma could allow the translocation of whole or digested bacteria across the gut epithelial barrier (3, 28) . Bacterial remnants may accumulate in the tissues of the reticuloendothelial system (RES). These depots of bacterial debris might serve as reservoirs for a persistent antigenic stimulus inducing and perpetuating diseases of unknown etiology.
Mur is readily demonstrated in body fluids in documented infection, including septic arthritis (7, 14, 27) , bacterial meningitis (23) , and urinary tract infections (2) . It has also been reported that Mur is detectable in reactive arthritis. However, in the majority of cases, the levels are so low that detection proves elusive (27) . These studies demonstrate the utility of nontraditional, gas chromatography-mass spectrometry (GC-MS) and more advanced GC-MS 2 techniques in demonstrating the presence of bacteria in human body fluids.
As noted above, Mur is not present in normal rat spleen. However, other studies have reported that Mur is found in human spleen (20, 31) . Although these human tissues were culture negative, they were from patients with gastric carcinoma or splenomegaly. In some cases of gastric carcinoma, at certain stages of the disease process, there may be an influx of bacteria or bacterial debris from the gastrointestinal flora. Splenomegaly might result from accumulation of bacteria or bacterial remnants from translocation across the gut epithelium. These studies employed high-performance liquid chromatography (HPLC) with fluorescence detection, which is extremely sensitive but lacks specificity and is best used as a screening technique. Observing a peak at the correct retention time is encouraging but not a definitive identification since one may merely be detecting a coeluting contaminant.
The purpose of the present study was to attempt to confirm these results using a methodology that provides unequivocal identification. Until the present study, GC-MS 2 has remained the state of the art. However, in the present report, it proved necessary to employ the next generation technique, GC-MS 3 , to even further lower detection limits.
MATERIALS AND METHODS
Rat spleens. Female Sprague-Dawley rats weighing Ϸ150 to 200 g were sacrificed, and the spleens were removed and weighed. Approximately 10 ml of sterile H 2 O was added to each organ for homogenization. Homogenized organs were lyophilized and stored at Ϫ70°C until analysis.
Human spleens. Portions of seven unfixed human spleens were obtained from the Pathology Department, University Hospital, Rotterdam, The Netherlands, immediately after surgery and were kept frozen (Ϫ20°C) until use. Spleens were removed for surgical and/or technical reasons from three patients with gastric carcinoma and from four patients because of splenomegaly due to hematologic diseases. All of the spleens were cultured under aerobic conditions on sheep blood agar. No bacterial growth was observed. The spleens analyzed by GC-MS 2 were the same ones analyzed previously by HPLC (31) .
Sample preparation for GC-MS 2 and GC-MS 3 . The alditol acetate derivatization procedure for Mur has been described elsewhere (13, 15) . Work from this laboratory has demonstrated the ubiquitous presence of Mur in dust (11, 22, 24) . Scrupulous attention was essential to eliminate environmental contamination of the samples. All samples were analyzed at least in duplicate. Samples were first hydrolyzed to release Mur from PG by the addition of 1 to 2 ml of 2 N sulfuric acid to 20 to 40 mg of lyophilized tissue (100 to 200 mg [wet weight]) for 3 h at 100°C. 13 C-labeled Mur was prepared in advance by hydrolyzing 40 mg of 13 Clabeled cyanobacteria (Isotec, Miamisburg, Ohio). The bacteria were 0.4% Mur on a dry weight basis. Thirty-four nanograms of 13 C-labeled Mur was added to each sample as an internal standard. Additionally, 50 g of glucose was added to each sample as a carrier. External standards consisted of a known amount of Mur and constant amounts (34 ng) of 13 C-labeled Mur. Blanks consisted of water spiked with 13 C-labeled Mur. Following hydrolysis, samples were neutralized by mixing with 2 to 4 ml of N,N-dioctylmethylamine (Fluka, Buchs, Switzerland) in chloroform (50:50 [vol/vol]) and centrifuged. The aqueous phase was removed and passed through C-18 columns (J&W Scientific, Folsom, Calif.) and reduced with 5 mg of sodium borohydride. To remove generated borate, methanol/acetic acid (200:1 [vol/vol]) was added continuously while evaporating under nitrogen. The samples were dried under vacuum. The alditols were acetylated at 100°C overnight. Acetic anhydride was decomposed with 0.75 ml of H 2 O. One milliliter of chloroform was added, and after mixing, the aqueous phase was discarded. Then, 0.8 ml of ammonium hydroxide in H 2 O (80:20 [vol/vol]) was added, the mixture was passed through a Chem Elut column (Varian, Walnut Creek, Calif.), and the organic phase was collected. The samples were evaporated to dryness and reconstituted in 25 to 30 l of chloroform prior to analysis.
Instrumentation. Samples were analyzed in the quantitation mode on a VG Quattro 1 triple quadrupole tandem mass spectrometer (Micromass, Boston, Mass.) coupled to a Fisons 8000 GC equipped with an automated sample injector (A200s) and a nonpolar, DB-5ms fused silica capillary column (J&W Scientific). Quantitation was based upon the peak area ratio of Mur to the internal standard ( 13 C-labeled Mur) in the sample compared with the peak area ratio in the external standard mixture (containing a known amount of Mur and 13 C-labeled Mur). Electron impact (EI) ionization was performed with a standard five-coil filament with an electron energy of 35 eV and emission current at 200 A. Source temperature was maintained at 225°C. Collision-induced disassociation (CID) of precursor ion mass of 402.98 for Mur and a mass of 411.98 for 13 C-labeled Mur was performed at a collision energy of 10 V. Mur and 13 Clabeled Mur were detected using the mass transitions 402.983197.84 and 411.983204.84, respectively, for quantitation.
In the identification mode (GC-MS 2 and GC-MS 3 ), samples were analyzed on a GCQ ion trap mass spectrometer (ThermoFinnigan, San Jose, Calif.) also equipped with an A200s autosampler and a DB-5ms ITD capillary column (J&W Scientific). Using MS 2 , identification was based on the similarity of the product ion spectrum (fingerprint) of a peak at the retention time of Mur in samples in comparison to the spectrum of a Mur standard. The parent molecule had a molecular weight (MW) of 403, and the same major fragments were observed: masses of 361, 301, 258, 240, 198, 156, and 138. The identity of these molecules has been described previously (23) . In MS 3 , characteristic fragment masses of 156 and 138 (parent transition 403.13198.1) were observed.
The injection port of the gas chromatograph was maintained at 250°C while the source temperature was maintained at 225°C. Initial oven temperature was 160°C for 1 min with the split valve closed and then a ramp of 20°C/min to 270°C and a hold for 1 min. Surge pressure was 75 lb/in 2 for 1 min. Helium was used as a carrier gas with a constant flow of 40 cm/s maintained with electronic pressure control on. EI ionization was performed with an electron energy of 70 eV and emission current at 250 A by using the standard autotune settings. For GC-MS 2 , the precursor ion with an m/z of 403 with a notch width of 1.0 mass unit was isolated for 16 ms. Collision energy was set at 1.10 V for 15 ms with a q of 0.225. In GC-MS 3 , parameters were identical for a precursor with an m/z ratio of 403; however, subsequent isolation of an m/z ratio of 198.1 with a 1.0 mass unit notch width for 16 ms and a collision energy of 0.6 V for 15 ms with a q of 0.225 was used.
RESULTS
The primary focus of this study was to determine whether Mur is present in culture-negative human spleen. This laboratory previously demonstrated categorically that Mur is not present in normal rat spleen by using GC-MS 2 (23) . There have been no previous studies using GC-MS 3 from this or any other laboratory. Thus, rat spleens were included as negative controls in all GC-MS 2 and GC-MS 3 experiments. Analysis for Mur in rat spleens using GC-MS 2 (quantitation mode). Normal rat spleens were analyzed by GC-MS 2 as negative controls. A detailed explanation for interpreting GC-MS 2 chromatograms (quantitation mode) and mass spectra (identification mode) was provided here (23) . In brief, natural (12) . The minor peak has not been identified. Figure 1A and B depict normal rat spleens and show no discernible peak at the retention time of the 13 C-labeled Mur (internal standard). Figure 1C shows the analyses of 100 mg of normal rat spleens spiked with 10 ng of Mur (positive control). Muramic acid is clearly present, illustrating the sensitivity and specificity of the technique. Both the major and the minor peaks for Mur are clearly observed.
Analysis for Mur in human spleen using GC-MS 2 (quantitation mode). Spleens removed from seven patients with underlying diseases (gastric carcinoma and hematologic diseases) were analyzed in duplicate. Six of the seven spleens showed no discernible peak for Mur in the quantification mode. In Fig.  2B , the top panels shows the absence of major or minor peak at the correct retention time for Mur. The top panel shows the characteristic twin peaks of the 13 C-labeled internal standard. In one case, however, Mur was detected confirming the HPLC results (31) . Figure 2A depicts the detection of 5 ng of Mur in 100 mg (wet weight) of human spleen. Previous HPLC analysis of these same human spleens suggested the presence of 400 to 600 ng of Mur in this mass of tissue.
Analysis for Mur in human spleen by using GC-MS 2 and GC-MS 3 (identification mode).
In GC-MS 2 identification mode (Fig. 3) , the major fragments observed during the second step of the instrumental analysis from mass 403 were 361, 301, 258, 240, 198, 156, and 138 (Fig. 3A) . These characteristic fragment masses provide a chemical fingerprint for Mur. Ten nanograms of Mur spiked in human spleen was readily identified (Fig. 3B) . The characteristic masses of 361, 301, 258, 240, 198, 156, and 138 are clearly visible. As noted above, Mur was detected in one human spleen without spiking at 5 ng/100 mg (wet weight) by GC-MS 2 (quantitation mode). However, the presence of Mur could not be confirmed in GC-MS 2 identification mode. Although some of the characteristic masses (258, 240, and 198) were observed, background present in the spec- (Fig. 3C) . A fingerprint of a typical human spleen is shown in Fig. 3D ; note that none of the characteristic masses were observed. To further reduce background, GC-MS 3 was employed. MS 3 employs a three-step instrumental analysis. The first two steps of the analysis were the same as in MS 2 . In the first stage, only molecules with a mass of 403 were isolated. In the second stage, these molecules were fragmented and only molecules with a mass of 198 were isolated. In the third stage, molecules of mass 198 were isolated and were further fragmented. In GC-MS 3 analysis, the characteristic fragment masses from 198
were MW 156 (minus 42 due to loss of ketene) and MW 138 (minus 60 due to loss of acetic acid). Figure 4A and B show the characteristic fingerprints of a Mur standard and a spiked human spleen in the GC-MS 3 identification mode and are essentially identical. Figure 4C shows the fingerprint of the unspiked human spleen. The characteristic fragments of MW 156 and 138 are unmistakable and provide categorical identification of Mur in a culture-negative human spleen. Figure 4D depicts the GC-MS 3 fingerprint of a human spleen that did not contain Mur. Neither characteristic fragment masses were observed. Normal rat spleens also did not contain Mur, as shown by GC-MS 3 analysis, and were identical to the other six culture-negative human spleens in lacking Mur.
DISCUSSION
Bacterial debris preferentially localizes in the spleen in experimental rat models of arthritis (9, 12, 17) . By extrapolation, it is reasonable to assume that in normal, healthy animals, bacterial debris processed by the host immune system might eventually find its way into tissues of the RES. However, in previous studies, it was demonstrated that Mur is not detectable in normal rat spleen (23, 35) . It is conceivable that in an underlying disease process, e.g., gastric carcinoma, large amounts of bacterial debris might pass through the gut into the circulation and localize in tissues (e.g., the spleen).
In support of this, it was previously reported that Mur was present in seven spleens of patients with gastric carcinoma or on August 27, 2017 by guest http://iai.asm.org/ hepatosplenomegaly due to hematologic disease. The spleens were analyzed using HPLC and Mur was detected fluorospectrometrically as a dansyl derivative, which detects amino sugars, amino acids, and other compounds containing amino groups. The levels of Mur reported in the spleens were 400 to 600 ng/100 mg of spleen (wet weight) (31) . In the present study, GC-MS 2 in the quantitation mode suggested the presence of Mur in only one of these spleens (5 ng Mur/100 mg [wet weight]). This level is 2 orders of magnitude lower than previously reported. It was not possible to use GC-MS 2 in the identification mode to provide confirmation due to excessive background peaks at these minute concentrations (ppb). The next generation technique of GC-MS 3 was required for categorical identification. It is probable that the levels of Mur in human spleen that were previously reported were spuriously elevated due to coeluting contaminants.
It is possible that Mur could have been degraded over time so that it was present at the time of the HPLC analyses and absent at the time of the GC-MS 2 analyses. However, samples were stored frozen under sterile conditions and there have been no mammalian enzymes described that degrade Mur. Another possible explanation for the discrepancy between the two studies is that the HPLC method used was more sensitive than GC-MS 2 . Thus, positive results by HPLC were below the limit of detection of GC-MS 2 . For a pure standard, it is probable that HPLC is comparable in sensitivity to GC-MS 2 . However, for complex biological samples, background from other components of the sample matrix determines the detection limit. MS 2 as a chromatographic detector dramatically lowers detection limits after GC separation. Fluorescence detection after HPLC detects any compound that contains a derivatized amino group (e.g., amino acids and sugars). There is a great deal of background with HPLC. However, it is worthy of note that the levels reported by others were 400 ng of Mur/100 mg (wet weight) of spleen. This is 2 orders of magnitude higher than our limit of detection (1 to 2 ng/100 mg). Thus, the lack of sensitivity of GC-MS 2 cannot explain the differences between the two studies. It would have been of interest to know whether the one GC-MS 2 -positive spleen was the one that gave the highest results for Mur in the HPLC method. Unfortunately, HPLC results in these studies were qualitative, while GC-MS 2 results were quantitative. A solid-phase immunoassay has been used to quantitate the levels of bacterial antigens in rats developing arthritis after a single injection of streptococcal cell walls. Using an antibody recognizing the D-alanine-D-alanine (D-Ala-D-Ala) determinant, PG was readily detected in all experimental tissues surveyed, including joints, with the largest amounts in the liver and spleen (9) . However, tissues from control rats (including joints and spleen) gave background values. These results are in agreement with results obtained by mass spectrometry analysis, demonstrating that the Mur portion of PG is not present in normal mammalian tissues as presented here.
More recently, an antibody recognizing the glycan backbone of PG (monoclonal antibody 2E9) was found to react with culture-negative human spleen (31) . This antibody also reacts with synovial cells from patients with rheumatoid arthritis, osteoarthritis, crystal arthritis, and joint trauma (32, 42) . Bacteria are not involved in the etiology of osteoarthritis, crystal arthritis, or joint trauma. It is possible that a PG moiety other than D-Ala-D-Ala or Mur is present in normal mammalian tissues (e.g., from prior bacterial infection). Alternatively, monoclonal antibody 2E9 staining of lymphoid cells may result from cross-reactivity between human glycoproteins or proteoglycans with the glycan backbone of PG. All of these antigens contain large amounts of glucosamine. Animals experimentally injected with cell walls from group A variant streptococci produce antibodies not only against the D-Ala-D-Ala determinant of PG but also against the polysaccharide backbone with Nacetylglucosamine as the immunodominant sugar (21, 29, 30) . Alternatively, when PG from Micrococcus lysodeikticus is used as the immunizing agent, antibodies directed against N-acetylmuramic acid are obtained. This is consistent with the structure of the M. lysodeikticus PG since only 40% of the Nacetylmuramic acid moieties are substituted by peptide subunits (43) .
The chronic inflammation in rheumatoid arthritis is in response to an undefined antigen. One possibility is the persistence of nonviable bacterial debris (including PG) stimulating inflammation in the rheumatoid joint. However, it is also possible that bacterial infections might lead to the induction of autoimmunity (e.g., from an immune response to the glycan backbone of PG).
In conclusion, Mur is not generally present in culture-negative human spleen or normal rat spleen. However, Mur was categorically detected in one of seven human spleens. Even in this spleen the levels of Mur were considerably lower than first reported (31) . For the first time, GC-MS 3 has been used to confirm the presence of Mur (or any microbial cell wall constituent) in a mammalian tissue. The fact that one of the spleens contained trace levels of Mur encourages further work to test the hypothesis that bacterial debris persisting in antigenpresenting cells could serve as a depot stimulating inflammatory diseases of unknown etiology.
